Bausch Health Companies (BHC) Net Income (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Net Income came in at $260.0 million in Q2 2026, up 103.12% year-over-year from $128.0 million in Q2 2025, and up 118.17% quarter-over-quarter from -$1.4 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Net Income (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Net Income across 18 years of filings, most recently posting $260.0 million for Q2 2026.
- In Q2 2026, Net Income rose 103.12% year-over-year to $260.0 million; the TTM figure through Jun 2026 stood at -$1.1 billion (down 2377.08% YoY), while the FY2025 annual figure was $120.0 million, up 266.67% from the prior year.
- Net Income came in at $260.0 million for Q2 2026 at Bausch Health Companies, up from -$1.4 billion in the prior quarter.
- In the past five years, Net Income ranged from a high of $403.0 million in Q3 2022 to a low of -$1.4 billion in Q1 2026.
- Average Net Income over 5 years is -$108.1 million, with a median of -$71.5 million recorded in 2022.
- Year-over-year, Net Income jumped 12900.0% in 2025 and sank 1563.95% in 2026.
- Over 5 years, Net Income stood at -$410.0 million in 2022, then soared by 88.54% to -$47.0 million in 2023, then jumped by 308.51% to $98.0 million in 2024, then tumbled by 205.1% to -$103.0 million in 2025, then soared by 352.43% to $260.0 million in 2026.
- Per Business Quant data, the three most recent Net Income figures were $260.0 million in Q2 2026, -$1.4 billion in Q1 2026, and -$103.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -576.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -118.80 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 45.93 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 69.61 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 260.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -66.70 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 24.70 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 30.35 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 1.97 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 260.00 Mn |
| Mar 31, 2026 | -1.43 Bn |
| Dec 31, 2025 | -103.00 Mn |
| Sep 30, 2025 | 181.00 Mn |
| Jun 30, 2025 | 128.00 Mn |
| Mar 31, 2025 | -86.00 Mn |
| Dec 31, 2024 | 98.00 Mn |
| Sep 30, 2024 | -92.00 Mn |
| Jun 30, 2024 | -1.00 Mn |
| Mar 31, 2024 | -77.00 Mn |
| Dec 31, 2023 | -47.00 Mn |
| Sep 30, 2023 | -382.00 Mn |
| Jun 30, 2023 | 27.00 Mn |
| Mar 31, 2023 | -209.00 Mn |
| Dec 31, 2022 | -410.00 Mn |
| Sep 30, 2022 | 403.00 Mn |
| Jun 30, 2022 | -139.00 Mn |
| Mar 31, 2022 | -66.00 Mn |
| Dec 31, 2021 | 72.00 Mn |
| Sep 30, 2021 | 191.00 Mn |